All Updates

All Updates

icon
Filter
Funding
Partnerships
CENTOGENE partners with Lifera; obtains USD 30 million loan
Precision Medicine
Jun 27, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Jun 27, 2023

CENTOGENE partners with Lifera; obtains USD 30 million loan

Funding
Partnerships

  • German commercial-stage diagnostic company CENTOGENE has formed a strategic collaboration with Lifera, a biopharmaceutical company owned by the Public Investment Fund. The collaboration aims to form a joint venture (JV) that will focus on providing multi-omic testing services in Saudi Arabia and the Gulf Cooperation Council countries.

  • As a part of the partnership agreement, CENTOGENE will receive a USD 30 million mandatory convertible loan from Lifera. The loan will have a six-month term and a conversion price of USD 2.20 per share of CENTOGENE's common stock. Additionally, CENTOGENE will also benefit from milestone payments and royalties related to the performance of the JV until 2033.

  • The partnership's objective is to improve local and regional access to advanced genetic testing by leveraging CENTOGENE's expertise and Lifera's local presence and resources. The JV will establish an advanced laboratory and bioinformatics infrastructure, utilizing CENTOGENE's biodata bank with over 70 million patient datasets, to offer state-of-the-art genetic sequencing tailored to regional needs. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.